CHINA COVID DELTA VARIANT
Can India’s Rafale slay China’s ‘Mighty Dragon’ deployed near LAC?
New satellite imagery reveals the deployment of J-20 stealth fighter jets by PLA Air Force near LAC. India seems confident that newly-acquired Rafale fighters and S-400 air defence systems can effectively thwart any Chinese threats
As COVID cases rise again, what do you need to know about the new FLiRT variants?
FLirt Covid 19 Virus: Scientists are studying the FLiRT variants, subvariants of the Omicron lineage, which may be more contagious and evade immunity better. The FLiRT variants, derived from the JN.1 variant, are demonstrating increased 'fitness' and may become the dominant subvariants in Australia. Booster shots targeting Omicron XBB.1.5 provide significant protection against severe illness.
China's third aircraft carrier heads to sea for the first time
China's third aircraft carrier, Fujian, showcases advanced technology with catapults for aircraft, aiming for a fleet of six carriers for operational maturity. Collin Koh highlights the strategic plan for China's carrier fleet expansion, emphasizing the significance of Type 003 carriers.
India records 203 fresh Covid cases, two deaths in 24 hours
India reported 203 Covid cases with an active caseload of 2,034, according to the Union Health Ministry. Two deaths were recorded in Kerala and Maharashtra. The rise in daily cases started after the emergence of a new variant and cold conditions. The JN.1 variant is not causing an exponential rise in cases or a surge in hospitalization and mortality. India has witnessed three COVID-19 waves, with the Delta wave in April-June 2021 being the peak. The country has administered 220.67 crore vaccine doses and has a national recovery rate of 98.81%.
Chinese health authorities say COVID-19 infections may rebound in January
China's fever clinic attendance has decreased, but health officials warn of a potential January rebound in COVID-19 infections. Despite low virus levels, the JN.1 variant is rising, prompting concerns. Experts anticipate a mix of respiratory pathogens in winter and spring, with influenza still prevalent. The shift to influenza B dominance, potential immunity decline, and the JN.1 variant's importation raise the risk of a January resurgence. Authorities stress early intervention, monitoring during winter holidays, and efficient medical resource allocation. Vaccination, especially for high-risk groups, is crucial to combat respiratory diseases.
Delhi: New Covid sub-variant on radar; flurry of surprise inspection of hospitals
The devastating third wave of the Covid pandemic driven by the Omicron variant had resulted in a record surge of infections in Delhi in early 2022, and the second one driven by the Delta variant had wreaked havoc in the national capital, as at other places, in 2021.
- Go To Page 1
"No need to panic, need to remain alert": AIIMS on new COVID subvariant JN.1
After a surge in the cases of the new COVID subvariant JN.1, doctors from the All India Institute of Medical Sciences (AIIMS) have advised people to not panic but rather remain alert and vigilant.
JN.1 Covid variant: Experts allay fears, cite low public health risk
Experts advocate a balanced perspective while dealing with new variants of SARS-CoV-2. Lahariya stressed the importance of continued vigilance and adherence to existing precautionary measures against JN.1, including the use of masks, maintaining hand hygiene, social distancing, avoiding crowded or poorly ventilated areas, and following proper cough etiquette.
Is the new COVID JN.1 variant more dangerous than previous ones? Here is what doctors are saying
A new strain of Covid-19, named JN.1, has been detected in Karakulam, Thiruvananthapuram district of Kerala. This variant, a descendant of Pirola, has now been identified in the US, China, and India. The JN.1 variant shares similarities with previous Omicron strains in terms of high transmissibility and mild symptoms. However, individuals should be aware of certain symptoms that may not be as mild as other Omicron variants.
Covid JN.1 virus arrives in India: What are the symptoms, precautions and should you worry?
A new sub-variant of the coronavirus, named JN.1, has been detected in a woman from Kerala, marking the first case in India. JN.1 is closely related to the BA.2.86 variant found in the US and China. It has an additional spike protein mutation, potentially making it more transmissible and capable of evading immunity.
JN.1 Covid-19 variant: Symptoms, transmission, vaccines, treatments and all information about the new variant
Heightened Coronavirus-related awareness, adherence to preventive measures, and a unified response will be pivotal in navigating the challenges posed by this and future variants, ultimately contributing to global efforts to overcome the COVID-19 pandemic.
New COVID subvariant JN.1 sparks concerns. Should you be worried? Know symptoms and more
China has found seven cases of the COVID subvariant JN.1, a new variant with an additional mutation on its spike protein. This variant, a descendant of the Omicron subvariant BA.2.86, has also emerged in the United States, drawing attention from health authorities worldwide. JN.1 makes up about 15% to 29% of cases in the United States as of December 8.
Eris: Symptoms, Vaccines and all about the new dominant Covid variant which is leading to a fresh wave in the U.S and U.K
The Eris variant, or EG.5, a dominant Covid subvariant, has surged to prominence as the most prevalent subvariant in the United States and the United Kingdom raising concerns.
New Covid variant Pirola not yet detected in India, tight vigil on: Insacog member
Insacog held a review meeting on Friday amidst increasing concern over the BA.2.86 variant, which is informally being termed Pirola. Its members were of the view that sewage testing for Covid-19 should be significantly increased "for timely detection of new variants like Pirola", the person said.
High levels of exposure to Covid virus may reduce protection from vaccination, prior infection: Study
The findings, published recently in the journal Nature Communications, suggest that in densely crowded settings, control measures that reduce levels of exposure to the virus -- such as masking, improved ventilation, and distancing -- may afford additional benefit in preventing new infections among people who have been vaccinated or previously infected.
Pan-Indian network of labs that monitor covid variations to hold meet for 'Eris'
India has reported 250-300 cases of the Covid-19 sub-variant EG.5.1, also known as Eris, and is being closely monitored by Insacog. No clustering or unusual surge has been observed so far, said an expert. While the World Health Organization has declared EG.5.1 a variant of interest, experts in India believe it is unlikely to cause a significant upsurge in daily cases.
China witnesses fresh wave of Covid cases from XBB variants
According to official media sources, quoted by The Washington Post, leading Chinese epidemiologist Zhong Nanshan on Monday said that two new vaccinations for the XBB omicron subvariants (including XBB. 1.9.1, XBB. 1.5, and XBB. 1.16) have been given preliminary approval.
No new strains detected in latest China Covid outbreak: Lancet analysis
According to the report, genome analysis of 413 new Covid-19 infections in Beijing spanning the period when China lifted its strictest pandemic control policies suggested that all were caused by existing strains.
XBB remains the dominant variant
INSACOG has not seen any "unusual pattern" or "clustering" in the country. "Severity depends on population immunity and local epidemiology. In the last few weeks we have seen cases going down contrary to the trend seen by some other countries, a senior government official said.
Covishield immune responses against Covid variants higher than Covaxin: Study
The yet-to-be peer-reviewed study, posted on the preprint server MedRxiv on Friday, also found that when compared to pre-vaccination baseline, both vaccines elicited statistically significant antibody levels in both seronegative individuals and seropositive or those who had recovered from Covid-19 infection.
Covid's BF.7 variant may not impact India as severely as China, says CCMB chief
Nandicoori said there is always a concern that all these variants have the ability to escape the immunity and can infect people who are vaccinated and even sometimes infected with the previous variants of Omicron. He urged citizens to follow a Covid-appropriate behaviour amid rising cases in the country.
India now has the BF.7 Omicron variant. Will masking, home isolation, and WFH make a comeback?
India has reported four cases of the Omicron sub-variant BF.7, which is causing the huge Covid surge in China. The BF.7 is a descendant of the BA.5, which was the last Omicron variant.
Will Covid variant BF.7 bring the world's fourth pandemic wave? Understand the difference with Delta
The lethal Delta variant, which began the terrible second wave in India in 2021, is not as transmissible as the BF.7 sub-variant.
What we know about the BF.7 coronavirus variant that has triggered fears of a fresh wave of infection
India has recently restarted random testing of international passengers, with the fear of a resurgent subvariant - the BF.7 - taking centrestage. Also referred to as Omicron Spawn, the coronavirus variant was first detected in India in October but is now making a comeback.
Experts warn of new Covid variants
Wang Guangfa, a respiratory expert from Peking University First Hospital, warned that Beijing may experience a spike in severe Covid-19 cases over the next fortnight. Engulfed by the latest wave, medical resources in the capital city are facing additional stress. The city is set to soon face peak caseload, Wang told state-run Global Times.
Load More
